Extended Resection of Locally Advanced Thymic Tumours in Stage III
Thieme. All rights reserved..
In the treatment of locally advanced thymic tumours, specific diagnostic testing is required, with a multimodal therapeutic approach consisting of surgery, radio- and/or chemotherapy. The complete resection of the tumour represents the most important prognostic factor with regard to recurrence-free and long-term survival. Local invasive growth of malignant thymic tumours into neighbouring mediastinal structures is classified as Masaoka-Koga stage III. Surgical resection can be performed primarily or after induction therapy, depending on the extent of the tumour. However, in some cases these tumours must be classified as non-resectable, so that only palliative radio-/chemotherapy remains as therapeutic option. TNM classification for malignant thymic tumours has been recently introduced. This resembles the established Masaoka-Koga classification in many aspects, but also includes some therapy-relevant changes. A differentiation is made between stages IIIA and IIIB, with the aim of assessing the resectability of advanced thymic tumours in a more differentiated manner and consequent planning of the therapy concept. Besides the thymus, thymoma, perithymic tissue, mediastinal pleura (stage I) or pericardium (stage II), all infiltrated structures should be removed "en bloc", if possible in stage III tumours. While the lung, brachiocephalic vessels or extrapericardial pulmonary vessels can still be resected and reconstructed if necessary, infiltration of the aorta or intrapericardial pulmonary vessels often limits macroscopically complete resection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:146 |
---|---|
Enthalten in: |
Zentralblatt fur Chirurgie - 146(2021), 1 vom: 10. Feb., Seite 119-125 |
Sprache: |
Deutsch |
---|
Weiterer Titel: |
Erweiterte Resektionsverfahren bei lokal fortgeschrittenen Tumoren des Thymus im Stadium III |
---|
Beteiligte Personen: |
Markowiak, Till [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 17.02.2021 Date Revised 17.02.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/a-1192-6961 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM312787804 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM312787804 | ||
003 | DE-627 | ||
005 | 20231225145151.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||ger c | ||
024 | 7 | |a 10.1055/a-1192-6961 |2 doi | |
028 | 5 | 2 | |a pubmed24n1042.xml |
035 | |a (DE-627)NLM312787804 | ||
035 | |a (NLM)32702766 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ger | ||
100 | 1 | |a Markowiak, Till |e verfasserin |4 aut | |
245 | 1 | 0 | |a Extended Resection of Locally Advanced Thymic Tumours in Stage III |
246 | 3 | 3 | |a Erweiterte Resektionsverfahren bei lokal fortgeschrittenen Tumoren des Thymus im Stadium III |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.02.2021 | ||
500 | |a Date Revised 17.02.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a In the treatment of locally advanced thymic tumours, specific diagnostic testing is required, with a multimodal therapeutic approach consisting of surgery, radio- and/or chemotherapy. The complete resection of the tumour represents the most important prognostic factor with regard to recurrence-free and long-term survival. Local invasive growth of malignant thymic tumours into neighbouring mediastinal structures is classified as Masaoka-Koga stage III. Surgical resection can be performed primarily or after induction therapy, depending on the extent of the tumour. However, in some cases these tumours must be classified as non-resectable, so that only palliative radio-/chemotherapy remains as therapeutic option. TNM classification for malignant thymic tumours has been recently introduced. This resembles the established Masaoka-Koga classification in many aspects, but also includes some therapy-relevant changes. A differentiation is made between stages IIIA and IIIB, with the aim of assessing the resectability of advanced thymic tumours in a more differentiated manner and consequent planning of the therapy concept. Besides the thymus, thymoma, perithymic tissue, mediastinal pleura (stage I) or pericardium (stage II), all infiltrated structures should be removed "en bloc", if possible in stage III tumours. While the lung, brachiocephalic vessels or extrapericardial pulmonary vessels can still be resected and reconstructed if necessary, infiltration of the aorta or intrapericardial pulmonary vessels often limits macroscopically complete resection | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Hofmann, Hans-Stefan |e verfasserin |4 aut | |
700 | 1 | |a Ried, Michael |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zentralblatt fur Chirurgie |d 1947 |g 146(2021), 1 vom: 10. Feb., Seite 119-125 |w (DE-627)NLM000011797 |x 1438-9592 |7 nnns |
773 | 1 | 8 | |g volume:146 |g year:2021 |g number:1 |g day:10 |g month:02 |g pages:119-125 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1192-6961 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 146 |j 2021 |e 1 |b 10 |c 02 |h 119-125 |